femMED launches comprehensive supplement solutions for most common women’s health concerns in the UAE

According to the market research report, by FMI Research, titled “Global Industry Analysis and Opportunity Assessment 2015-2025”, the global dietary supplement market is expected to reach USD$253 billion by 2025, reflecting a CAGR of 7.4. Growth of the industry is mainly driven by rising consumer health awareness and an inclination towards prevention of health problems.

The comprehensive solutions provided by femMED are well received in a market dominated by single ingredient products. The femMED product range is developed to the highest standards of ingredients and manufacturing processes. In the UAE, femMED partnered with NewBridge Pharmaceuticals, a well-established specialised regional healthcare company with headquarters in Dubai.

Commenting on femMED’s launch in the UAE, Dr. Baher Massoud, Chief Medical Officer – Africa, Middle East & Turkey, NewBridge Pharmaceuticals, said: “We are delighted to launch a new line of high quality all-natural supplements to physicians and patients in the UAE. femMED is delivering doctor-formulated products that will address unmet health needs and improve the overall well-being of women in the UAE.”

The rapid growth experienced by the global supplements market has been attributed to increasing healthcare costs that are influencing a shift by consumers to products such as health supplements. In addition, with increasing age, it is difficult for the body to absorb the optimum levels of nutrients required from food, which is where supplements have become a popular option. Dr. Massoud added:

“By developing vitamins that target specific areas of women’s health, such as Bone Health or Hair, Skin and Nails, we are helping women identify and select a product that is suitable for their individual needs. Our solutions are developed by doctors, but easily recognized and understood by consumers. By eliminating the ‘guess work’ often associated with supplements, we ensure that women are only consuming what they actually require.”

Manufactured in Canada, femMED’s supplements contain only the highest quality vitamins, minerals, and herbs. The products are free of dairy, egg, artificial colors and flavors, and most are gluten free. The capsules are vegetable-based. In the UAE, five vitamin supplement lines are available, including Bone Health; Hair, Skin, and Nails; Pregnancy; Pregnancy + Ginger; and Multi + Antioxidants.

About femMED

Founded in 2007, femMED is a brand of comprehensive supplements designed specifically for the unique needs of women. femMED’s line of 20 doctor-formulated remedies provide natural solutions to women’s most common health concerns, at every age and stage of life. Five of these remedies are currently available in the UAE. Each product contains only the highest quality vitamins, minerals and herbs, with each ingredient backed by extensive research and clinical studies. All femMED formulations are free of gluten, dairy, egg, artificial colours and flavours, and almost all are yeast-free, suitable for vegetarians and delivered in vegetable capsules. femMED formulas are designed to work on their own, or in combination with other femMED formulas to achieve multiple health goals. All products are produced in Canadian pharmaceutically licensed facilities. For more information about femMED supplements, please visit www.femmed.com.

About NewBridge Pharmaceuticals

NewBridge Pharmaceuticals is a first-in-class specialty therapeutics company focused on pharmaceuticals, biologics, medical diagnostics and other innovative healthcare products serving the AfMET markets (Africa, Middle East and Turkey) to address the unmet medical needs of diseases with high regional prevalence. Headquartered in the UAE with strong local and international business network, NewBridge is uniquely positioned as the partner-of-choice for pharmaceutical, biotechnology and other healthcare companies seeking to create value for their pharma or medical products in the high growth emerging AfMET markets. For more information, please visit www.nbpharma.com.